The store will not work correctly when cookies are disabled.
2-methoxy-[1,3]dioxolo[4,5-g]naphtho[1,2-c]cinnoline
ID: ALA5186082
PubChem CID: 9861272
Max Phase: Preclinical
Molecular Formula: C18H12N2O3
Molecular Weight: 304.31
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2c(ccc3c4cc5c(cc4nnc23)OCO5)c1
Standard InChI: InChI=1S/C18H12N2O3/c1-21-11-3-5-12-10(6-11)2-4-13-14-7-16-17(23-9-22-16)8-15(14)19-20-18(12)13/h2-8H,9H2,1H3
Standard InChI Key: IMPABAXTBFQROU-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 27 0 0 0 0 0 0 0 0999 V2000
-1.2277 1.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9421 0.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9421 -0.0999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2277 -0.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5132 -0.0999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5132 0.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2013 -0.5125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9157 -0.0999 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9158 0.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2012 1.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6303 1.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6303 1.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9158 2.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2013 1.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3448 0.7249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0593 1.1373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0594 1.9623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3449 2.3748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7266 0.9800 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2115 0.3126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7268 -0.3547 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7739 2.3746 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7740 3.1997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
9 10 2 0
6 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
9 11 1 0
14 10 1 0
15 16 2 0
16 17 1 0
17 18 2 0
11 15 1 0
18 12 1 0
19 20 1 0
2 19 1 0
20 21 1 0
3 21 1 0
5 7 1 0
8 9 1 0
7 8 2 0
17 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 304.31 | Molecular Weight (Monoisotopic): 304.0848 | AlogP: 3.67 | #Rotatable Bonds: 1 |
Polar Surface Area: 53.47 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.95 | CX LogP: 2.98 | CX LogD: 2.98 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.50 | Np Likeness Score: -0.18 |
References
1. Talukdar A, Kundu B, Sarkar D, Goon S, Mondal MA.. (2022) Topoisomerase I inhibitors: Challenges, progress and the road ahead., 236 [PMID:35413618] [10.1016/j.ejmech.2022.114304] |